A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Study Details
Study Description
Brief Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to Epidermolysis Bullosa
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with Epidermolysis Bullosa Patients who have been diagnosed with Epidermolysis Bullosa |
Other: No intervention
There is no intervention for this study
|
Outcome Measures
Primary Outcome Measures
- Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing [Three years]
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with Epidermolysis Bullosa
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study i. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
-
Male or female of all ages. (interest is given to children who present with autism or Crohn's and whose parents wish to analyze their children's gut flora. Also of interest analysis of development of the child's microbiome. In the case of autism, the younger the child, the better to correct the neurological problems if an association is found between autism and the microbiome)
-
Diagnosis of Epidermolysis by at least one of the following i. Biopsy ii. Genetic testing
Exclusion Criteria:
-
Refusal to sign informed consent form
-
History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
-
Postoperative stoma, ostomy, or ileoanal pouch
-
Participation in any experimental drug protocol within the past 12 weeks
-
Treatment with total parenteral nutrition
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ProgenaBiome | Ventura | California | United States | 93003 |
Sponsors and Collaborators
- ProgenaBiome
Investigators
- Principal Investigator: Sabine Hazan, MD, ProgenaBiome
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PRG-034